Anti-depressant potentiation of 5-hydroxytryptophan by L-deprenyl, an MAO ?type B? inhibitor
- 1 September 1978
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 43 (3) , 279-286
- https://doi.org/10.1007/bf01246965
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- MONOAMINE-OXIDASE INHIBITORS AND PROLACTIN SECRETIONThe Lancet, 1977
- IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASEThe Lancet, 1977
- Multiple forms of monoamine oxidase: Fact and artefactLife Sciences, 1976
- Analysis of the Pharmacological Effects of Selective Monoamine Oxidase InhibitorsPublished by Wiley ,1976
- Introduction to Clinical Aspects of Monoamine Oxidase Inhibitors in the Treatment of DepressionPublished by Wiley ,1976
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975
- PLASMA CONCENTRATION OF AMITRIPTYLINE AND CLINICAL RESPONSEThe Lancet, 1972
- SEQUENTIAL COMPARISON OF L-TRYPTOPHAN WITH E.C.T. IN SEVERE DEPRESSIONThe Lancet, 1970
- TYRAMINE IN CHEESE RELATED TO HYPERTENSIVE CRISES AFTER MONOAMINE-OXIDASE INHIBITIONThe Lancet, 1965
- HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORSThe Lancet, 1963